The FDA has added a warning label to bluebird bio's Skysona, after launching an investigation into cases of blood cancer in patients treated with the ex vivo gene therapy last November. Skysona ...
Zscaler's price target has seen a slight uptick following new earnings and guidance, climbing from $327.98 to $328.22. This increase comes as analysts weigh the company's strong performance in new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback